141A — Trial Holdings Balance Sheet
0.000.00%
- ¥439bn
- ¥768bn
- ¥1tn
Annual balance sheet for Trial Holdings, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 27,432 | 23,898 | 91,947 | 72,325 | 68,901 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,012 | 973 | 1,170 | 3,300 | 18,564 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 76,365 | 82,114 | 152,300 | 143,172 | 201,806 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 94,953 | 102,999 | 113,694 | 136,549 | 240,892 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 185,730 | 200,639 | 283,627 | 300,283 | 807,824 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 97,046 | 107,666 | 143,010 | 151,064 | 599,692 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 127,769 | 134,753 | 167,943 | 174,158 | 676,921 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 57,961 | 65,886 | 115,684 | 126,125 | 130,903 |
| Total Liabilities & Shareholders' Equity | 185,730 | 200,639 | 283,627 | 300,283 | 807,824 |
| Total Common Shares Outstanding |